CLINICAL_TRIALS
trial_result
· 2013-03-07
Clinical Trial Update: Ranolazine for Improving Symptoms of Palpitations [Phase 4]
Summary
A Phase 4 clinical trial evaluating ranolazine for improving palpitations in ischemic heart disease. The current status is listed as UNKNOWN.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Roma La Sapienza | Conditions: Ischemic Heart Disease | Phase 4 | Status: UNKNOWN